A subsidiary of DCC PLC*, a leading international sales, marketing and support service group and a constituent of the FTSE 100, DCC Vital specialises in the sales, marketing and distribution of a broad range of pharmaceuticals, medical, surgical and laboratory products to healthcare professionals and patients in the UK, Ireland and international markets.
Every day, thousands of healthcare providers across the world rely on medical devices from DCC Vital.
Our offering is diverse – we sell and distribute a broad range of own brand and third party medical products – but our focus is single minded: to deliver solutions that make a difference to patient care.
Our passionate team of 1000 staff support over 40,000 product lines and supply over half a million orders to healthcare providers every year. No matter what their role or location, our staff all share the same passion to improve patient care, utilising the breadth and quality of the DCC Vital portfolio and the strength of our customer and supplier relationships.
This is a time of terrific growth for DCC Vital. Over the past five years, through a combination of acquisition and organic growth we have more than doubled the scale of our business, providing us with a platform for growth in our existing markets and new growth areas.
But our drive doesn’t stop here, DCC Vital has an ambitious expansion strategy and we are constantly seeking new opportunities to grow our product portfolio and establish new channels.
As we continue to grow, we will innovate and expand our offering further, to proactively help our customers adapt to whatever market changes and medical advances lie ahead.
*DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2021, DCC generated revenue of £13.4 billion and operating profit of £530.2 million.
